Rhinomed noses ahead after winning Victorian testing deal
MELBOURNE: Shares in “nasal technology” biotech Rhinomed are up 14.7 per cent just before lunch
MELBOURNE: Shares in “nasal technology” biotech Rhinomed are up 14.7 per cent just before lunch
FEATURED
Construction loan now secured for innovative seniors community
Senior living operators plan more moderate rental rate growth
10-storey apartments under 1500-home plan around golf course
High rise living above casino pitched to boomer market
Pilot study to improve staff interactions with residents with dementia
Senior living marketing leaps into digital age with innovations
INNOVATION
